Antisense102
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Antisense102, covering 2025-05-07 to 2025-05-07. Get the full timeline:
Most recent: Clinical Trial Update: Antisense102: Pilot Immunotherapy for Newly Diagnosed Malignant Glioma [Phase 1]